Citigroup
IMCR icon

Citigroup’s Immunocore IMCR Stock Holding History

Citigroup’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683K Buy
21,514
+16,997
+376% +$503K ﹤0.01% 3725
2026
Q1 		$136K Sell
4,517
-2,383
-35% -$77.1K ﹤0.01% 4167
2025
Q4 		$239K Sell
6,900
-218,410
-97% -$7.71M ﹤0.01% 3913
2025
Q3 		$8.19M Sell
225,310
-409,191
-64% -$13.9M ﹤0.01% 1634
2025
Q2 		$19.9M Sell
634,501
-4,787
-0.7% -$149K 0.01% 957
2025
Q1 		$19M Buy
639,288
+6,344
+1% +$190K 0.01% 1002
2024
Q4 		$18.7M Buy
632,944
+616,912
+3,848% +$19.5M 0.01% 1000
2024
Q3 		$499K Buy
16,032
+6,299
+65% +$229K ﹤0.01% 3728
2024
Q2 		$330K Sell
9,733
-12,762
-57% -$651K ﹤0.01% 3639
2024
Q1 		$1.46M Buy
22,495
+18,356
+443% +$1.26M ﹤0.01% 2711
2023
Q4 		$283K Buy
4,139
+1,148
+38% +$59.7K ﹤0.01% 3752
2023
Q3 		$155K Sell
2,991
-671
-18% -$39.7K ﹤0.01% 3775
2023
Q2 		$220K Buy
3,662
+3,322
+977% +$190K ﹤0.01% 3850
2023
Q1 		$16.8K Sell
340
-6
-2% -$337 ﹤0.01% 4565
2022
Q4 		$19.7K Buy
+346
New +$19.5K ﹤0.01% 4602

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Citigroup's IMCR Position: Q2 2026 in Review

Citigroup increased its Immunocore (IMCR) stake by 376% in Q2 2026, buying an estimated $503K and bringing the position to 21,514 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.

Citigroup first reported a position in IMCR in Q4 2022 and has held it in 15 quarters since. The position peaked at $19.9M in Q2 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Citigroup held 21,514 shares of Immunocore worth $683K as of Q2 2026.
  • Citigroup bought 16,997 Immunocore shares in Q2 2026, an estimated $503K.
  • Immunocore made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3725 holding.
  • Citigroup first reported a position in Immunocore in Q4 2022 and has held it in 15 quarters since.
  • Citigroup's Immunocore position peaked at $19.9M in Q2 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.